Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma

World Journal of Gastroenterology

Volumn 12, Issue 44, 2006, Pages 7188-7191

  Chou, Nan Hua ^a   Chen, Hui Chun ^b   Chou, Nan Song ^c   Hsu, Ping I ^a   Tseng, Hui Hwa ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c Chi Mei Foundation Hospital   (Taiwan)

Author keywords

Altered retinoblastoma protein; Gastric adenocarcinoma; Immunhistochemistry

Indexed keywords

ETOPOSIDE; FLUOROURACIL; METHOTREXATE; RETINOBLASTOMA PROTEIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH SURGERY; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS;

EID: 33845421766     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i44.7188     Document Type: Article

References (23)

1. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 1995; 147: 545-560
2. Weinberg RA. Tumor suppressor genes. Science 1991; 254: 1138-1146
3. Sellers WR, Kaelin WG Jr. Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol 1997; 15: 3301-3312
4. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma. and osteosarcoma. Nature 1986; 323: 643-646
5. Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH, Benedict WF. Structural evidence for the authenticity of the human retinoblastoma. gene. Science 1987; 236: 1657-1661
6. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987; 235: 1394-1399
7. Reissmann PT, Simon MA, Lee WH, Slamon DJ. Studies of the retinoblastoma gene in human sarcomas. Oncogene 1989; 4: 839-843
8. Hui AM, Li X, Makuuchi M, Takayama T, Kubota K. Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int J Cancer 1999; 84: 604-608
9. Furukawa Y, DeCaprio JA, Belvin M, Griffin JD. Heterogeneous expression of the product of the retinoblastoma susceptibility gene in primary human leuken-da cells. Oncogene 1991; 6: 1343-1346
10. zur Hausen A, Sarbia M, Heep H, Willers R, Gabbert HE. Retinoblastoma-protein (prb) expression and prognosis in squamous-cell carcinomas of the esophagus. Int J Cancer 1999; 84: 618-622
11. Varley JM, Armour J, Swallow JE, Jeffreys AJ, Ponder BA, T'Ang A, Fung YK, Brammar WJ, Walker RA. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene 1989; 4: 725-729
12. Cairns P, Proctor AJ, Knowles MA. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 1991; 6: 2305-2309
13. Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE, Lee WH. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 1990; 87: 7762-7766
14. Sakaguchi M, Fujii Y, Hirabayashi H, Yoon HE, Komoto Y, Oue T, Kusafuka T, Okada A, Matsuda H. Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int J Cancer 1996; 65: 442-445
15. Bartek J, Vojtesek B, Grand RJ, Gallimore PH, Lane DP. Cellular localization and T antigen binding of the retinoblastoma protein. Onrogene 1992; 7: 101-108
16. Geradts J, Hu SX, Lincoln CE, Benedict WF, Xu HJ. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer 1994; 58: 161-167
17. Xu HJ, Cairns P, Hu SX, Knowles MA, Benedict WF. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int J Cancer 1993; 53: 781-784
18. Constancia M, Seruca R, Carneiro F, Silva F, Castedo S. Retinoblastoma gene structure and product expression in human gastric carcinoma. Br J Cancer 1994; 70: 1018-1024
19. Benedict WF, Xu HJ, Hu SX, Takahashi R. Role of the retinoblastoma gene in the initiation and progression of human cancer. J Clin Invest 1990; 85: 988-993
20. Phillips SM, Barton CM, Lee SJ, Morton DG, Wallace DM, Lemoine NR, Neoptolemos JP. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br J Cancer 1994; 70: 1252-1257
21. Poller DN, Baxter KJ, Shepherd NA. p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 1997; 75: 87-93
22. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE. Altered expression of the retinoblastoma gene product prognostic indicator in bladder cancer. J Natl Cancer Inst 1992; 84: 1251-1256
23. Xu HJ, Quinlan DC, Davidson AG, Hu SX, Summers CL, Li J, Benedict WF. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J Natl Cancer Inst 1994; 86: 695-699